Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

LY-293558. Eli Lilly & Co.

Gilron I.

Curr Opin Investig Drugs. 2001 Sep;2(9):1273-8. Review.

PMID:
11717815
2.

YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

Takahashi M, Kohara A, Shishikura J, Kawasaki-Yatsugi S, Ni JW, Yatsugi S, Sakamoto S, Okada M, Shimizu-Sasamata M, Yamaguchi T.

CNS Drug Rev. 2002 Winter;8(4):337-52. Review.

3.

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

Bullock R, Graham DI, Swanson S, McCulloch J.

J Cereb Blood Flow Metab. 1994 May;14(3):466-71.

PMID:
8163588
4.

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.

Ornstein PL, Arnold MB, Augenstein NK, Lodge D, Leander JD, Schoepp DD.

J Med Chem. 1993 Jul 9;36(14):2046-8. No abstract available.

PMID:
8393116
5.

4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.

Stutzmann JM, Bohme GA, Boireau A, Damour D, Debono MW, Genevois-Borella A, Imperato A, Jimonet P, Pratt J, Randle JC, Ribeill Y, Vuilhorgne M, Mignani S.

Bioorg Med Chem Lett. 2000 May 15;10(10):1133-7.

PMID:
10843235
6.

Glutamate receptor antagonists in the management of migraine.

Chan K, MaassenVanDenBrink A.

Drugs. 2014 Jul;74(11):1165-76. doi: 10.1007/s40265-014-0262-0. Review.

PMID:
25030431
7.

Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.

Gitto R, Barreca ML, De Luca L, De Sarro G, Ferreri G, Quartarone S, Russo E, Constanti A, Chimirri A.

J Med Chem. 2003 Jan 2;46(1):197-200.

PMID:
12502375
8.

AMPA glutamate receptors and neuropathic pain.

Morales-Alcelay S, Rubio L, Martinez A.

Mini Rev Med Chem. 2003 Nov;3(7):757-63. Review.

PMID:
14529516
9.

Non-competitive AMPA antagonists of 2,3-benzodiazepine type.

Sólyom S, Tarnawa I.

Curr Pharm Des. 2002;8(10):913-39. Review.

PMID:
11945139
10.

Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.

Stutzmann JM, Bohme GA, Boireau A, Damour D, Debono MW, Genevois-Borella A, Jimonet P, Pratt J, Randle JC, Ribeill Y, Vuilhorgne M, Mignani S.

Bioorg Med Chem Lett. 2001 May 7;11(9):1205-10.

PMID:
11354378
11.

Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers.

Petersen KL, Iyengar S, Chappell AS, Lobo ED, Reda H, Prucka WR, Verfaille SJ.

Pain. 2014 May;155(5):929-36. doi: 10.1016/j.pain.2014.01.019.

PMID:
24486883
12.

Glutamate AMPA receptor antagonist treatment for ischaemic stroke.

Akins PT, Atkinson RP.

Curr Med Res Opin. 2002;18 Suppl 2:s9-13.

PMID:
12365832
13.

Ruboxistaurin (Eli Lilly).

Wheeler GD.

IDrugs. 2003 Feb;6(2):159-63. Review.

PMID:
12789620
14.

Dapoxetine: LY 210448.

[No authors listed]

Drugs R D. 2005;6(5):307-11. Review.

PMID:
16128601
15.

AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.

Périer C, Marin C, Bonastre M, Tolosa E, Hirsch EC.

Eur J Neurosci. 2002 Dec;16(11):2236-40.

PMID:
12473092
16.

The AMPA receptor binding site: focus on agonists and competitive antagonists.

Stensbøl TB, Madsen U, Krogsgaard-Larsen P.

Curr Pharm Des. 2002;8(10):857-72. Review.

PMID:
11945136
19.

Effect of intrathecal non-NMDA EAA receptor antagonist LY293558 in rats: a new class of drugs for spinal anesthesia.

Von Bergen NH, Subieta A, Brennan TJ.

Anesthesiology. 2002 Jul;97(1):177-82.

PMID:
12131120
20.

Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.

Matucz E, Móricz K, Gigler G, Simó A, Barkóczy J, Lévay G, Hársing LG Jr, Szénási G.

Brain Res. 2004 Sep 3;1019(1-2):210-6.

PMID:
15306255
Items per page

Supplemental Content

Support Center